150 related articles for article (PubMed ID: 16584158)
1. Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene.
Pignatello R; Ricupero N; Bucolo C; Maugeri F; Maltese A; Puglisi G
AAPS PharmSciTech; 2006 Mar; 7(1):E27. PubMed ID: 16584158
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of Eudragit Retard nanosuspensions for the ocular delivery of cloricromene.
Pignatello R; Ricupero N; Bucolo C; Maugeri F; Maltese A; Puglisi G
AAPS PharmSciTech; 2006 Mar; 7(1):E192-E198. PubMed ID: 28290042
[TBL] [Abstract][Full Text] [Related]
3. Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene.
Bucolo C; Maltese A; Maugeri F; Busà B; Puglisi G; Pignatello R
J Pharm Pharmacol; 2004 Jul; 56(7):841-6. PubMed ID: 15233861
[TBL] [Abstract][Full Text] [Related]
4. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
Pignatello R; Bucolo C; Ferrara P; Maltese A; Puleo A; Puglisi G
Eur J Pharm Sci; 2002 Jul; 16(1-2):53-61. PubMed ID: 12113891
[TBL] [Abstract][Full Text] [Related]
5. Ocular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery.
Pignatello R; Bucolo C; Puglisi G
J Pharm Sci; 2002 Dec; 91(12):2636-41. PubMed ID: 12434408
[TBL] [Abstract][Full Text] [Related]
6. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
Pignatello R; Bucolo C; Spedalieri G; Maltese A; Puglisi G
Biomaterials; 2002 Aug; 23(15):3247-55. PubMed ID: 12102196
[TBL] [Abstract][Full Text] [Related]
7. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Katara R; Majumdar DK
Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
[TBL] [Abstract][Full Text] [Related]
8. Flurbiprofen release from Eudragit RS and RL aqueous nanosuspensions: a kinetic study by DSC and dialysis experiments.
Castelli F; Messina C; Sarpietro MG; Pignatello R; Puglisi G
AAPS PharmSciTech; 2002; 3(2):E9. PubMed ID: 12916946
[TBL] [Abstract][Full Text] [Related]
9. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application.
Agnihotri SM; Vavia PR
Nanomedicine; 2009 Mar; 5(1):90-5. PubMed ID: 18823824
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form.
Leo E; Brina B; Forni F; Vandelli MA
Int J Pharm; 2004 Jun; 278(1):133-41. PubMed ID: 15158956
[TBL] [Abstract][Full Text] [Related]
12. Sulfacetamide loaded Eudragit® RL100 nanosuspension with potential for ocular delivery.
Mandal B; Alexander KS; Riga AT
J Pharm Pharm Sci; 2010; 13(4):510-23. PubMed ID: 21486528
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres.
Devrim B; Bozkir A; Canefe K
Acta Pol Pharm; 2011; 68(4):593-9. PubMed ID: 21796942
[TBL] [Abstract][Full Text] [Related]
14. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling.
Ali HS; York P; Ali AM; Blagden N
J Control Release; 2011 Jan; 149(2):175-81. PubMed ID: 20946923
[TBL] [Abstract][Full Text] [Related]
15. Nanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18.
Pardeike J; Müller RH
Int J Pharm; 2010 May; 391(1-2):322-9. PubMed ID: 20214969
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride.
Das SK; Das NG
J Microencapsul; 1998; 15(4):445-52. PubMed ID: 9651866
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
Kocbek P; Baumgartner S; Kristl J
Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459
[TBL] [Abstract][Full Text] [Related]
18. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
Verma P; Gupta RN; Jha AK; Pandey R
Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
Nath B; Nath LK; Kumar P
Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of polymeric and lipid nanoparticles of pilocarpine HCl for ocular application.
Lütfi G; Müzeyyen D
Pharm Dev Technol; 2013; 18(3):701-9. PubMed ID: 22813238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]